newsfilter
← Latest News
GlobeNewswire·

Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors

WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with